Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Jubilant Pharmova Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

75/100
1,160.90
-20.30 (-1.72%)

As on 06 Nov, 2025 | 03:59

Open Trading A/c
Day Range
1143.20
1170.00
L H
52 Week Range
802.00
1309.90
L H
Volume
180,691
*
i

* BSE Market Depth (06 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
100 1150.50 1170.00 80
1 1149.95 1171.00 1
10 1145.00 1180.00 151
2 1144.00 1181.25 10
151 1143.30 1184.90 3
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
75/100
1,166.70
-14.55 (-1.23%)

As on 06 Nov, 2025 | 04:01

Open Trading A/c
Day Range
1144.50
1169.95
L H
52 Week Range
823.70
1309.00
L H
Volume
16,163
*
i

* BSE Market Depth (06 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
100 1150.50 1170.00 80
1 1149.95 1171.00 1
10 1145.00 1180.00 151
2 1144.00 1181.25 10
151 1143.30 1184.90 3
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE
MC Essentials
82% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 1,169.80
          Previous Close 1,181.20
          Volume 180,691.00
          Value (Lacs) 2,097.64
            VWAP 1,156.89
          Beta
          Mkt Cap (Rs. Cr.) 18,491
          High 1,170.00
          Low 1,143.20
          UC Limit 1,417.40
          LC Limit 945.00
          52 Week High 1,309.90
          52 Week Low 802.00
          Face Value 1.00
          All Time High 1,309.90
          All Time Low 3.48
          20D Avg Volume 210,933
          20D Avg Delivery(%) 53.54
          Book Value Per Share 372.96
          Dividend Yield 0.43
          TTM EPS See historical trend 29.99 (-20.11% YoY)
          TTM PE See historical trend 38.71 (Average PE)
          P/B See historical trend 3.12 (High P/B)
          Sector PE 39.80

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          75/100
          Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 11.37% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 47.68% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 17 years Jubilant Pharmova has given positive returns in November.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          November 39.01% (2013) 11.90% -13.95% (2010) -7.19% 4.04%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Jubilant Life

          What's your call on Jubilant Life today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          18 Mar, 2025

          East Bridge Capital Master Fund Limited

          Qty 623585 Price 856.25 % Traded 0.38
          18 Mar, 2025

          East Bridge Capital Master Fund I Ltd

          Qty 623585 Price 856.25 % Traded 0.38

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          13 Jun, 2025

          Jubilant Enpro Private Limited

          Qty 2116000 Price 1060 % Traded 1.29
          13 Jun, 2025

          Nikita Resources Private Limited

          Qty 1962434 Price 1060.37 % Traded 1.19
          13 Jun, 2025

          Kotak Mahindra Mutual Fund

          Qty 1693434 Price 1060 % Traded 1.03
          13 Jun, 2025

          Kotak Funds - India Midcap Fund

          Qty 1593500 Price 1060 % Traded 0.97
          13 Sep, 2024

          Graviton Research Capital Llp

          Qty 825289 Price 1157.72 % Traded 0.50
          13 Sep, 2024

          Graviton Research Capital Llp

          Qty 825289 Price 1158.18 % Traded 0.50

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Jubilant Pharmo 1,160.90 -1.72 18,490.95 38.71 3.11 13.41 -6.86 836 7,234 0.39
          Sun Pharma 1,685.90 -0.24 404,503.88 39.00 5.60 15.13 -7.75 10,980 52,578 0.03
          Divis Labs 6,883.50 1.16 182,735.30 79.24 12.21 14.63 15.61 2,191 9,360 0.00
          Cipla 1,501.50 -0.12 121,286.85 22.29 3.89 16.90 -5.81 5,291 27,547 0.00
          Torrent Pharma 3,553.40 -0.60 120,263.20 60.07 16.03 25.17 10.70 1,911 11,516 0.40
          + See More

          About the Company

          Jubilant Life Sciences Limited, is an integrated Pharmaceutical & Life Sciences company. As India`s largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solutions provider out of India, it is constantly engaged in delivering value to its global customers through innovative technologies, products and services. The Company`s strategic focus is to innovate, collaborate and accelerate the process of delivering products to the market for its customers. Today, it is well recognized as a leading global pharmaceutical and Life Sciences companies. .The company also in the business activities of Life Sciences Ingredients, Pharmaceuticals & Life Science Products & Services.
          {"success":1,"data":{"address":{"address1":"Bhartiagram,","address2":"\nGajraula,,","city":"Amroha District","state":"Uttar Pradesh","pincode":"244223","telephone1":"05924-267437","telephone2":"","fax1":"05924-252352","fax2":"","email":"investors@jubl.com","web":"http:\/\/www.jubilantpharmova.com"},"management":[{"name":"Shyam S Bhartia","designation":"Chairman"},{"name":"Hari S Bhartia","designation":"Co-Chairman"},{"name":"Priyavrat Bhartia","designation":"Managing Director"},{"name":"Arjun Shanker Bhartia","designation":"Joint Managing Director"},{"name":"Arvind Chokhany","designation":"WholeTime Director & Group CFO"}],"registrars":{"name":"Alankit Assignment Ltd.","address1":"205-208, Anarkali Complex,\nJhandewalan Extension,","address2":"","address3":"","address4":"","telephone":"011-42541954, 42541234","fax":"011-41543474","email":"","internet":"http:\/\/www.alankit.com","city":"New Delhi","state":"Delhi","pincode":"110055"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"Yes"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"530019","nseId":"JUBLPHARMA","series":"EQ","isinid":"INE700A01033"}}}

          • Registered Office

          • Registrars

            • Address

              205-208, Anarkali Complex, Jhandewalan Extension,,

            • City

              New Delhi 110055

            • State

              Delhi

            • Tel. No.

              011-42541954, 42541234

            • Fax No.

              011-41543474

            • Email

            • Internet

              http://www.alankit.com

          • Management

            • Shyam S Bhartia

              Chairman

            • Hari S Bhartia

              Co-Chairman

            • Priyavrat Bhartia

              Managing Director

            • Arjun Shanker Bhartia

              Joint Managing Director

            • Arvind Chokhany

              WholeTime Director & Group CFO

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              Yes

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              530019

            • NSE:

              JUBLPHARMA

            • Series

              EQ

            • ISIN

              INE700A01033

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347